Trial intelligence / Profile preview

Exubera vs Lispro in T2DM on Lantus

NCT00348374Phase 3Completed

Sponsor
Pfizer
Start
Jun 2006
Primary completion
Aug 2008
Modality
Biologic
Countries
2
01

Overview

A Phase 3 trial of insulin human in type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Jun 2006; status: completed.

02

Drugs

insulin human
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00348374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00348374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call